Retinoblastoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Retinoblastoma Microchapters
Home
Patient Information
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Retinoblastoma from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural history, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
History & Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Retinoblastoma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Retinoblastoma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Retinoblastoma epidemiology and demographics
CDC on Retinoblastoma epidemiology and demographics
Retinoblastoma epidemiology and demographics in the news
Blogs on Retinoblastoma epidemiology and demographics
Directions to Hospitals Treating Retinoblastoma
Risk calculators and risk factors for Retinoblastoma epidemiology and demographics

There is no predisposition for retinoblastoma by race or gender. Right and left eyes are affected equally. The incidence of retinoblastoma worldwide ranges from 1 in 14,000 live births to 1 in 34,000.

See also

• Eye cancer
• Eye examination

Template:WikiDoc Sources